BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imwattana K, Knight DR, Kullin B, Collins DA, Putsathit P, Kiratisin P, Riley TV. Antimicrobial resistance in Clostridium difficile ribotype 017. Expert Rev Anti Infect Ther 2020;18:17-25. [PMID: 31800331 DOI: 10.1080/14787210.2020.1701436] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 O’grady K, Knight DR, Riley TV. Antimicrobial resistance in Clostridioides difficile. Eur J Clin Microbiol Infect Dis. [DOI: 10.1007/s10096-021-04311-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Lew T, Putsathit P, Sohn KM, Wu Y, Ouchi K, Ishii Y, Tateda K, Riley TV, Collins DA. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015. Antimicrob Agents Chemother 2020;64:e00296-20. [PMID: 32393487 DOI: 10.1128/AAC.00296-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Imwattana K, Putsathit P, Knight DR, Kiratisin P, Riley TV. Molecular Characterization of, and Antimicrobial Resistance in, Clostridioides difficile from Thailand, 2017-2018. Microb Drug Resist 2021. [PMID: 33956520 DOI: 10.1089/mdr.2020.0603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wickramage I, Spigaglia P, Sun X. Mechanisms of antibiotic resistance of Clostridioides difficile. J Antimicrob Chemother 2021:dkab231. [PMID: 34297842 DOI: 10.1093/jac/dkab231] [Reference Citation Analysis]
5 Imwattana K, Putsathit P, Collins DA, Leepattarakit T, Kiratisin P, Riley TV, Knight DR. Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017. Microb Genom 2022;8. [PMID: 35316173 DOI: 10.1099/mgen.0.000792] [Reference Citation Analysis]
6 Putsathit P, Hong S, George N, Hemphill C, Huntington PG, Korman TM, Kotsanas D, Lahra M, McDougall R, McGlinchey A, Moore CV, Nimmo GR, Prendergast L, Robson J, Waring L, Wehrhahn MC, Weldhagen GF, Wilson RM, Riley TV, Knight DR. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18. J Antimicrob Chemother 2021;76:1815-21. [PMID: 33895826 DOI: 10.1093/jac/dkab099] [Reference Citation Analysis]
7 Collins DA, Wu Y, Tateda K, Kim HJ, Vickers RJ, Riley TV. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile. J Antimicrob Chemother 2021;76:967-72. [PMID: 33351917 DOI: 10.1093/jac/dkaa522] [Reference Citation Analysis]
8 Imwattana K, Rodríguez C, Riley TV, Knight DR. A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile. Microb Genom 2021;7. [PMID: 34793295 DOI: 10.1099/mgen.0.000696] [Reference Citation Analysis]
9 Lim SC, Hain-Saunders NMR, Imwattana K, Putsathit P, Collins DA, Riley TV. Genetically related Clostridium difficile from water sources and human CDI cases revealed by whole-genome sequencing. Environ Microbiol 2021. [PMID: 34693624 DOI: 10.1111/1462-2920.15821] [Reference Citation Analysis]
10 Waker E, Ambrozkiewicz F, Kulecka M, Paziewska A, Skubisz K, Cybula P, Targoński Ł, Mikula M, Walewski J, Ostrowski J. High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years. Front Microbiol 2020;11:1618. [PMID: 32793147 DOI: 10.3389/fmicb.2020.01618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]